Cited by 24Electronic Health Records SystemsArtificial Intelligence in Healthcare and EducationTechnology and Human Factors in Education and Health

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Initial experience with AI Pathway Companion: Evaluation of dashboard-enhanced clinical decision making in prostate cancer screening

Open access

Abstract

Purpose: Rising complexity of patients and the consideration of heterogeneous information from various IT systems challenge the decision-making process of urological oncologists. Siemens AI Pathway Companion is a decision support tool that provides physicians with comprehensive patient information from various systems. In the present study, we examined the impact of providing organized patient information in comprehensive dashboards on information quality, effectiveness, and satisfaction of physicians in the clinical decision-making process. Methods: Ten urologists in our department performed the entire diagnostic workup to treatment decision for 10 patients in the prostate cancer screening setting. Expenditure of time, information quality, and user satisfaction during the decision-making process with AI Pathway Companion were recorded and compared to the current workflow. Results: A significant reduction in the physician’s expenditure of time for the decision-making process by -59.9% (p < 0,001) was found using the software. System usage showed a high positive effect on evaluated information quality parameters completeness (Cohen’s d of 2.36), format (6.15), understandability (2.64), as well as user satisfaction (4.94). Conclusion: The software demonstrated that comprehensive organization of information improves physician’s effectiveness and satisfaction in the clinical decision-making process. Further development is needed to map more complex patient pathways, such as the follow-up treatment of prostate cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0271183

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A recent study evaluated urologists' use of an AI tool (Siemens AI Pathway Companion) to assist in CDM for ten patients with prostate cancer.

    “A recent study evaluated urologists’ use of an AI tool (Siemens AI Pathway Companion; Siemans Healthcare, Germany) to assist in CDM for ten patients with prostate cancer. 15”

    From The use of an artificial intelligence platform OpenEvidence to augment clinical decision-making for primary care physicians (2025) · cites this paper as [15]

    The Abstract (Methods) says ten urologists used AI Pathway Companion in decision-making for ten patients. The Methods (Study design) specifies that the patients were undergoing prostate cancer screening; it does not establish that all ten had prostate cancer. One case was recommended for monitoring rather than biopsy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The AI tool provided the urologists with an aggregated dashboard of relevant disease-specific information leading to diagnostic and therapeutic recommendations.

    “The AI tool provided the urologists with an aggregated dashboard of relevant disease-specific information (e.g., prostate-specific antigen, prostate MRI, pathology) leading to diagnostic and therapeutic recommendations. 15”
  • Urologists had a significant reduction in time spent on CDM (−59%; P < .001) and had improved satisfaction when using the tool compared to normal CDM.

    “Urologists had a significant reduction in time spent on CDM (−59%; P < .001) and had improved satisfaction when using the tool compared to normal CDM. 15”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. G. Melzer, 2021, Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials, Appl Clin Inform, 12, 17, 10.1055/s-0040-1721010 · DOI
  2. P. Knaup, 2001, On the necessity of systematically planning clinical tumor documentation, Methods Inf Med, 40, 90, 10.1055/s-0038-1634482 · DOI
  3. Bansal, S.K. Towards a Semantic Extract-Transform-Load (ETL) Framework for Big Data Integration. in 2014 IEEE International Congress on Big Data. 2014. · DOI
  4. A.L. Kostrinsky-Thomas, 2021, Searching the PDF Haystack: Automated Knowledge Discovery in Scanned EHR Documents, Appl Clin Inform, 12, 245, 10.1055/s-0041-1726103 · DOI
  5. M. Becker, 2020, Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment, Appl Clin Inform, 11, 200, 10.1055/s-0040-1705105 · DOI
  6. M. Henkel, 2020, Structured Data Acquisition in Oncology, Oncology, 98, 423, 10.1159/000504259 · DOI
  7. S. Mate, 2015, Ontology-based data integration between clinical and research systems, PloS one, 10, 10.1371/journal.pone.0116656 · DOI
  8. A. Maedche, 2001, Ontology learning for the Semantic Web, IEEE Intelligent Systems, 16, 72, 10.1109/5254.920602 · DOI
  9. F. Liu, 2012, Clinical Research Informatics, 293, 10.1007/978-1-84882-448-5_16 · DOI
  10. I. Tamposis, 2022, PCaGuard: A Software Platform to Support Optimal Management of Prostate Cancer, Appl Clin Inform, 13, 91, 10.1055/s-0041-1741481 · DOI
  11. Tamposis, I., et al. HPVGuard: A software platform to support management and prognosis of cervical cancer. in 2014 4th International Conference on Wireless Mobile Communication and Healthcare-Transforming Healthcare Through Innovations in Mobile and Wireless Technologies (MOBIHEALTH). 2014. IEEE. · DOI
  12. P. Unberath, 2020, EHR-Independent Predictive Decision Support Architecture Based on OMOP, Appl Clin Inform, 11, 399, 10.1055/s-0040-1710393 · DOI
  13. J.L. Kwan, 2020, Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials, BMJ, 370, m3216, 10.1136/bmj.m3216 · DOI
  14. H. Wickham, 2016, ggplot2: elegant graphics for data analysis, 10.1007/978-3-319-24277-4 · DOI
  15. M. Jayaratne, 2019, A data integration platform for patient-centered e-healthcare and clinical decision support, Future Generation Computer Systems, 92, 996, 10.1016/j.future.2018.07.061 · DOI
  16. P. Van Herck, 2010, Systematic review: Effects, design choices, and context of pay-for-performance in health care, BMC Health Serv Res, 10, 247, 10.1186/1472-6963-10-247 · DOI
  17. D. Fowler, 2019, Effect of digital tumor board solutions on “failure-to-discuss” rates for patient cases during tumor boards, Journal of Clinical Oncology, 37, 308, 10.1200/JCO.2019.37.27_suppl.308 · DOI
  18. S. Van de Velde, 2018, The GUIDES checklist: development of a tool to improve the successful use of guideline-based computerised clinical decision support, Implementation Science, 13, 86, 10.1186/s13012-018-0772-3 · DOI
  19. K. Kawamoto, 2005, Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success, BMJ, 330, 765, 10.1136/bmj.38398.500764.8F · DOI · Paper page
  20. M.A. Musen, 2014, Biomedical informatics, 643, 10.1007/978-1-4471-4474-8_22 · DOI
  21. M. Al-Jaghbeer, 2018, Clinical Decision Support for In-Hospital AKI, J Am Soc Nephrol, 29, 654, 10.1681/ASN.2017070765 · DOI

Cited by

Sorted by citations

Metadata

Authors
Henkel, M., Horn, T., Leboutte, F., Trotsenko, P., Dugas, S. G., Sutter, S. U., Ficht, G., Engesser, C., Matthias, M., Stalder, A., Ebbing, J., Cornford, P., Seifert, H., Stieltjes, B., & Wetterauer, C.
Affiliations
  • University of Basel (CH)
  • Liverpool University Hospitals NHS Foundation Trust (GB)
  • Danube Private University (AT)
Corresponding author
Henkel, Maurice
Venue
PLOS ONE
Published
2022-07-20
Volume
17
Issue
7
Pages
e0271183
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4286209811
Cited by
24
References
1
Citations by year
2026: 2 · 2025: 9 · 2024: 6 · 2023: 7
FWCI
4.12
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Siemens Healthineers
Topics
  • Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Technology and Human Factors in Education and Health
Keywords
clinical decision support, prostate cancer screening, clinical dashboards, physician information needs, information quality, user satisfaction, urologic oncology
MeSH terms
Clinical Decision-Making, Artificial Intelligence, Decision Making, Humans, Male, Prostatic Neoplasms, Prostate-Specific Antigen, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review